Metabolic dysfunction-associated fatty liver disease (MAFLD)
Conditions
Interventions
Intervention group:Health and Physical Activity Management Plan based on Health Action Process Approach (HAPA) Theory
Control group:Conventional Management Plan for MAFLD
Sponsors
Affiliated Children's Hospital of Jiangnan University
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: (1) Meets the diagnostic criteria for pediatric metabolic-associated fatty liver disease as defined by the 2020 International Expert Consensus Statement. (2) Conforms to the standards for screening overweight and obesity in school-age children and adolescents issued and implemented by the National Health Commission in 2018. (3) Aged between 6 and 12 years old. (4) Possesses good communication and comprehension abilities, capable of expressing feelings and intentions accurately. (5) The legal guardian of the research subject agrees to participate in this study and signs the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Those who have taken drugs such as atorvastatin in the past 3 months. (2) Individuals with comorbid cardiovascular diseases, renal dysfunction, or cancer. (3) Those currently participating in other research studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| controlled attenuation parameter (CAP) value;height;weight;waist circumference;hip circumference;visceral fat area;percent body fat; | — |
Secondary
| Measure | Time frame |
|---|---|
| the Weight Efficacy Lifestyle Questionnaire-ShortForm (WEL-SF);the Chinese version of the Self-Efficacy for Exercise Scale (SEE-C); | — |
Countries
China
Contacts
Public ContactZhang Le
Affiliated Children's Hospital of Jiangnan University
Outcome results
None listed